TrialDiabetes, obesity & metabolism2025

Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes.

Andreea Ciudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.